Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles
Vertex Pharmaceuticals is expanding into endocrine disease drugs through a $10 billion acquisition of Crinetics.
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Where it stands
Vertex Pharmaceuticals has entered into a $10 billion deal to acquire Crinetics. This strategic move represents a foray into the development of endocrine disease drugs.
Coverage from Endpoints News and BioPharma Dive emphasizes that the acquisition is a significant step for Vertex toward the top ranks of the biopharma industry. Investor's Business Daily and Seeking Alpha report that Crinetics' stock doubled following the announcement.
Future developments center on the integration of the two companies and the progress of the targeted endocrine disease drug pipeline.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 45d ago.
Sources (4)
- Vertex's $10B Crinetics deal marks its clearest step yet toward biopharma's top ranks Endpoints News · 45d ago
- Vertex to acquire Crinetics in $10B foray into endocrine disease drugs BioPharma Dive · 45d ago
- Biggest stock movers Tuesday: CRNX, RIVN, DOCN, and more Seeking Alpha · 45d ago
- Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles Investor's Business Daily · 45d ago broke it first
Answered
How much is Vertex paying for Crinetics?
The deal is valued at $10 billion.
What happened to Crinetics' stock price?
According to Investor's Business Daily, the stock doubled.
What is the purpose of this acquisition?
The deal marks Vertex's entry into endocrine disease drugs.
People, places & organizations
Topics
From around our network
- The 1934 Law That Makes Your Mailbox Off-Limits daybreakwire.com
Related trends
Walmart to finally start accepting Apple Pay and Google Pay
Walmart and Sam's Club are finally adding Apple Pay, Google Pay, and other tap-to-pay options.
Trump Announces Beef Tariff Relief — and Takes Jab at Biden
Tariff relief for imported beef aims to lower high costs ahead of the midterms.
Exclusive | Nvidia in Talks to Invest in Data-Center Power Developer Cloverleaf Infrastructure
Nvidia is in advanced talks to invest hundreds of millions in data-center power developer Cloverleaf Infrastructure.
How Micron's $50 billion Boise buildout is reshaping its hometown
A massive $50 billion buildout in Boise is fundamentally reshaping the hometown of semiconductor giant Micron.
China Evergrande founder sentenced to life in prison
Evergrande’s founder receives a life sentence, sending shockwaves through China’s property market and creditor landscape.
SK Hynix shares surge over 12% in Seoul after announcing massive stock buyback
SK Hynix shares jumped over 12% in Seoul following a massive stock buyback announcement.